Skip to main content

Marex Group plc

Position in QURE — uniQure N.V.

CIK 1997464 London, X0

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,753,890
+$2,445,678 QoQ
Shares Held
81,500
+1.9% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#85
of 252 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Mar 31, 2026
CallValue
$327,000
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Marex Group plc holds $88,179,553 across 55 Biotechnology names. QURE ranks #7 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 QURE
uniQure N.V.
This page
81,500 $3,753,890

All Filings in QURE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,753,890 81,500
2026-03-31 $1,308,212 80,013
2026-03-31 $327,000 20,000
2025-12-31 $2,057,812 85,993
2025-09-30 $5,069,959 86,859
2025-03-31 $848,000 80,000
2024-12-31 $1,412,800 80,000
2024-09-30 $394,400 80,000
2024-06-30 $358,400 80,000
2024-03-31 $416,000 80,000
2023-12-31 $541,600 80,000